239 related articles for article (PubMed ID: 19133257)
1. The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells.
Kiyan J; Haller H; Dumler I
Exp Cell Res; 2009 Apr; 315(6):1029-39. PubMed ID: 19133257
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.
Kiyan J; Smith G; Haller H; Dumler I
Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta.
Kiyan J; Kiyan R; Haller H; Dumler I
EMBO J; 2005 May; 24(10):1787-97. PubMed ID: 15889147
[TBL] [Abstract][Full Text] [Related]
4. Tyk2 mediates effects of urokinase on human vascular smooth muscle cell growth.
Patecki M; von Schaewen M; Tkachuk S; Jerke U; Dietz R; Dumler I; Kusch A
Biochem Biophys Res Commun; 2007 Aug; 359(3):679-84. PubMed ID: 17548050
[TBL] [Abstract][Full Text] [Related]
5. Urokinase receptor associates with myocardin to control vascular smooth muscle cells phenotype in vascular disease.
Kiyan Y; Limbourg A; Kiyan R; Tkachuk S; Limbourg FP; Ovsianikov A; Chichkov BN; Haller H; Dumler I
Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):110-22. PubMed ID: 22075245
[TBL] [Abstract][Full Text] [Related]
6. Monocyte-expressed urokinase regulates human vascular smooth muscle cell migration in a coculture model.
Kusch A; Tkachuk S; Lutter S; Haller H; Dietz R; Lipp M; Dumler I
Biol Chem; 2002 Jan; 383(1):217-21. PubMed ID: 11928816
[TBL] [Abstract][Full Text] [Related]
7. Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell.
Lugano R; Peña E; Badimon L; Padró T
J Thromb Haemost; 2012 Oct; 10(10):2158-67. PubMed ID: 22906080
[TBL] [Abstract][Full Text] [Related]
8. UPA promotes lipid-loaded vascular smooth muscle cell migration through LRP-1.
Lugano R; Peña E; Casani L; Badimon L; Padró T
Cardiovasc Res; 2013 Nov; 100(2):262-71. PubMed ID: 23812296
[TBL] [Abstract][Full Text] [Related]
9. Different migration of vascular smooth muscle cells from human coronary artery bypass vessels. Role of Rho/ROCK pathway.
Weiss S; Frischknecht K; Greutert H; Payeli S; Steffel J; Lüscher TF; Carrel TP; Tanner FC
J Vasc Res; 2007; 44(2):149-56. PubMed ID: 17264516
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of red and white wines on inhibition of the platelet-derived growth factor receptor: impact of the mash fermentation.
Sparwel J; Vantler M; Caglayan E; Kappert K; Fries JW; Dietrich H; Böhm M; Erdmann E; Rosenkranz S
Cardiovasc Res; 2009 Mar; 81(4):758-70. PubMed ID: 19074160
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling: role for the urokinase receptor.
Kiyan J; Kusch A; Tkachuk S; Krämer J; Haller H; Dietz R; Smith G; Dumler I
Atherosclerosis; 2007 Dec; 195(2):254-61. PubMed ID: 17275828
[TBL] [Abstract][Full Text] [Related]
12. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
13. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
[TBL] [Abstract][Full Text] [Related]
14. oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4.
Kiyan Y; Tkachuk S; Hilfiker-Kleiner D; Haller H; Fuhrman B; Dumler I
J Mol Cell Cardiol; 2014 Jan; 66():72-82. PubMed ID: 24239845
[TBL] [Abstract][Full Text] [Related]
15. Urokinase signal transduction and its role in cell migration.
Carlin SM; Resink TJ; Tamm M; Roth M
FASEB J; 2005 Feb; 19(2):195-202. PubMed ID: 15677342
[TBL] [Abstract][Full Text] [Related]
16. Urokinase activates macrophage PON2 gene transcription via the PI3K/ROS/MEK/SREBP-2 signalling cascade mediated by the PDGFR-beta.
Fuhrman B; Gantman A; Khateeb J; Volkova N; Horke S; Kiyan J; Dumler I; Aviram M
Cardiovasc Res; 2009 Oct; 84(1):145-54. PubMed ID: 19497963
[TBL] [Abstract][Full Text] [Related]
17. The tight junction protein ZO-2 mediates proliferation of vascular smooth muscle cells via regulation of Stat1.
Kusch A; Tkachuk S; Tkachuk N; Patecki M; Park JK; Dietz R; Haller H; Dumler I
Cardiovasc Res; 2009 Jul; 83(1):115-22. PubMed ID: 19380416
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of dehydrozingerone on vascular smooth muscle cell function.
Liu Y; Dolence J; Ren J; Rao M; Sreejayan N
J Cardiovasc Pharmacol; 2008 Nov; 52(5):422-9. PubMed ID: 19033821
[TBL] [Abstract][Full Text] [Related]
19. Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.
Franco P; Vocca I; Carriero MV; Alfano D; Cito L; Longanesi-Cattani I; Grieco P; Ossowski L; Stoppelli MP
J Cell Sci; 2006 Aug; 119(Pt 16):3424-34. PubMed ID: 16882693
[TBL] [Abstract][Full Text] [Related]
20. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view.
Binder BR; Mihaly J; Prager GW
Thromb Haemost; 2007 Mar; 97(3):336-42. PubMed ID: 17334498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
